Krebs Biochemicals and Industries Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krebs Biochemicals and Industries Limited has submitted a routine compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025. The certificates were issued by KFIN Technologies Limited, the company's Registrar and Share Transfer Agent, and submitted to both CDSL and NSDL, the two Indian depositories. These certificates confirm that the details of all securities dematerialized and rematerialized during the quarter have been properly furnished to BSE and NSE, where the company's shares are listed under scrip codes 524518 and KREBSBIO respectively. This is a standard, recurring quarterly filing mandated by SEBI for all listed companies, with no material business or financial content.
This is a routine regulatory compliance filing and carries no material impact on the company's operations, financials, or share price. Investors should note it only as confirmation that the company is meeting its quarterly depository-related reporting obligations.